Summary
Instrumentation Laboratory Co (IL), a subsidiary of Werfen Life Group, is a medical device company which focuses on in-vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, reagents, and data management solutions across the world. Its major products include critical care systems including whole blood analyzers, CO-Oximeter, and whole-blood coagulation system; hemostasis systems including testing systems, reagents, controls, and calibrators; and information management systems. IL also offers various quality control products; and services such as advanced automation, quality management, clinical support, and product support. The company offers products to hospitals and independent clinical laboratories. IL is headquartered in Bedford, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Instrumentation Laboratory Co
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
- Instrumentation Laboratory Co Company Overview
- Instrumentation Laboratory Co Company Snapshot
- Instrumentation Laboratory Co Pipeline Products and Ongoing Clinical Trials Overview
- Instrumentation Laboratory Co – Pipeline Analysis Overview
- Business Description
- Instrumentation Laboratory Co - Key Facts
- Instrumentation Laboratory Co - Major Products and Services
- Instrumentation Laboratory Co Pipeline Products by Development Stage
- Instrumentation Laboratory Co Pipeline Products Overview
- ACL AcuStar - aß2GPI Domain I Assay
- ACL AcuStar - aß2GPI Domain I Assay Product Overview
- ACL AcuStar - HIT Total ab Test
- ACL AcuStar - HIT Total ab Test Product Overview
- ACL AcuStar - VWF: RCo Assay
- ACL AcuStar - VWF: RCo Assay Product Overview
- ACL AcuStar - VWF:Ag Assay
- ACL AcuStar - VWF:Ag Assay Product Overview
- ACL TOP 300 CTS System - Apixaban Test
- ACL TOP 300 CTS System - Apixaban Test Product Overview
- ACL TOP 300 CTS System - Dabigatran Test
- ACL TOP 300 CTS System - Dabigatran Test Product Overview
- ACL TOP 300 CTS system - Global Protein C Pathway Test
- ACL TOP 300 CTS system - Global Protein C Pathway Test Product Overview
- ACL TOP 300 CTS System - HIT Assay
- ACL TOP 300 CTS System - HIT Assay Product Overview
- ACL TOP 300 CTS System - Rivaroxaban Test
- ACL TOP 300 CTS System - Rivaroxaban Test Product Overview
- ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay
- ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay Product Overview
- ACL TOP 350 CTS System - Apixaban Test
- ACL TOP 350 CTS System - Apixaban Test Product Overview
- ACL TOP 350 CTS System - Dabigatran Test
- ACL TOP 350 CTS System - Dabigatran Test Product Overview
- ACL TOP 350 CTS System - Rivaroxaban Test
- ACL TOP 350 CTS System - Rivaroxaban Test Product Overview
- ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay
- ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
- ACL TOP 500 CTS System - Apixaban Test
- ACL TOP 500 CTS System - Apixaban Test Product Overview
- ACL TOP 500 CTS System - Dabigatran Test
- ACL TOP 500 CTS System - Dabigatran Test Product Overview
- ACL TOP 500 CTS System - Global Protein C Pathway Test
- ACL TOP 500 CTS System - Global Protein C Pathway Test Product Overview
- ACL TOP 500 CTS System - HIT Test
- ACL TOP 500 CTS System - HIT Test Product Overview
- ACL TOP 500 CTS System - Rivaroxaban Test
- ACL TOP 500 CTS System - Rivaroxaban Test Product Overview
- ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay
- ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
- ACL TOP 550 CTS System - Apixaban Test
- ACL TOP 550 CTS System - Apixaban Test Product Overview
- ACL TOP 550 CTS System - Dabigatran Test
- ACL TOP 550 CTS System - Dabigatran Test Product Overview
- ACL TOP 550 CTS System - Rivaroxaban Test
- ACL TOP 550 CTS System - Rivaroxaban Test Product Overview
- ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay
- ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
- ACL TOP 700 - HIT Test
- ACL TOP 700 - HIT Test Product Overview
- ACL TOP 700 System - Apixaban Test
- ACL TOP 700 System - Apixaban Test Product Overview
- ACL TOP 700 System - Dabigatran Test
- ACL TOP 700 System - Dabigatran Test Product Overview
- ACL TOP 700 System - Global Protein C Pathway Test
- ACL TOP 700 System - Global Protein C Pathway Test Product Overview
- ACL TOP 700 System - Rivaroxaban Test
- ACL TOP 700 System - Rivaroxaban Test Product Overview
- ACL TOP 700 System - VWF Ristocetin Cofactor Activity Assay
- ACL TOP 700 System - VWF Ristocetin Cofactor Activity Assay Product Overview
- ACL TOP 750 CTS System - Apixaban Test
- ACL TOP 750 CTS System - Apixaban Test Product Overview
- ACL TOP 750 CTS System - Dabigatran Test
- ACL TOP 750 CTS System - Dabigatran Test Product Overview
- ACL TOP 750 CTS System - Rivaroxaban Test
- ACL TOP 750 CTS System - Rivaroxaban Test Product Overview
- ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay
- ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay Product Overview
- GEM Premier 4000 Analyzer - BUN
- GEM Premier 4000 Analyzer - BUN Product Overview
- GEM Premier 4000 Analyzer - tCO2 Test
- GEM Premier 4000 Analyzer - tCO2 Test Product Overview
- HemosIL AcuStar Multi-Ab Controls
- HemosIL AcuStar Multi-Ab Controls Product Overview
- HemosIL Apixaban Testing Assay
- HemosIL Apixaban Testing Assay Product Overview
- HemosIL Dabigatran Calibrators
- HemosIL Dabigatran Calibrators Product Overview
- HemosIL Dabigatran Controls
- HemosIL Dabigatran Controls Product Overview
- HemosIL Direct Thrombin Inhibitor Assay
- HemosIL Direct Thrombin Inhibitor Assay Product Overview
- HemosIL Rivaroxaban Calibrators
- HemosIL Rivaroxaban Calibrators Product Overview
- HemosIL Rivaroxaban Controls
- HemosIL Rivaroxaban Controls Product Overview
- POC Enzymatic Creatinine Assay
- POC Enzymatic Creatinine Assay Product Overview
- ROTEM sigma Thromboelastometry System
- ROTEM sigma Thromboelastometry System Product Overview
- Instrumentation Laboratory Co - Key Competitors
- Instrumentation Laboratory Co - Key Employees
- Instrumentation Laboratory Co - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Instrumentation Laboratory Co, Recent Developments
- Mar 10, 2020: Instrumentation Laboratory launches new GEM Premier ChemSTAT Testing System with iQM In the US
- Oct 08, 2019: Instrumentation Laboratory awarded 2019 IMV ServiceTrak award for best Hemostasis System performance
- Sep 19, 2019: Instrumentation Laboratory launches HemosIL AcuStar ADAMTS13 activity assay in Europe and other international markets
- Sep 04, 2019: Instrumentation Laboratory awarded point-of-care coagulation/patient blood management agreement with Premier
- Aug 05, 2019: Instrumentation Laboratory presents new GEM Premier ChemSTAT Testing System with iQM at American Association For Clinical Chemistry Annual Meeting
- May 06, 2019: Instrumentation Laboratory worldwide sales top $1 billion in 2018
- Mar 06, 2019: Instrumentation Laboratory receives US FDA clearance for new Gem Premier Chemstat Testing System
- May 07, 2018: Instrumentation Laboratory Worldwide Sales Top $970 M In 2017
- Oct 16, 2017: Instrumentation Laboratory Receives US FDA Clearance For HemosIL AcuStar HIT-IgG(PF4-H) Assay And Controls
- Jul 31, 2017: Instrumentation Laboratory Launches GEMweb Plus 500 Custom Connectivity Worldwide
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Instrumentation Laboratory Co Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Instrumentation Laboratory Co Pipeline Products by Equipment Type
- Table 3: Instrumentation Laboratory Co Pipeline Products by Indication
- Table 4: Instrumentation Laboratory Co, Key Facts
- Table 5: Instrumentation Laboratory Co, Major Products and Services
- Table 6: Instrumentation Laboratory Co Number of Pipeline Products by Development Stage
- Table 7: Instrumentation Laboratory Co Pipeline Products Summary by Development Stage
- Table 8: ACL AcuStar - aß2GPI Domain I Assay - Product Status
- Table 9: ACL AcuStar - aß2GPI Domain I Assay - Product Description
- Table 10: ACL AcuStar - HIT Total ab Test - Product Status
- Table 11: ACL AcuStar - HIT Total ab Test - Product Description
- Table 12: ACL AcuStar - VWF: RCo Assay - Product Status
- Table 13: ACL AcuStar - VWF: RCo Assay - Product Description
- Table 14: ACL AcuStar - VWF:Ag Assay - Product Status
- Table 15: ACL AcuStar - VWF:Ag Assay - Product Description
- Table 16: ACL TOP 300 CTS System - Apixaban Test - Product Status
- Table 17: ACL TOP 300 CTS System - Apixaban Test - Product Description
- Table 18: ACL TOP 300 CTS System - Dabigatran Test - Product Status
- Table 19: ACL TOP 300 CTS System - Dabigatran Test - Product Description
- Table 20: ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Status
- Table 21: ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Description
- Table 22: ACL TOP 300 CTS System - HIT Assay - Product Status
- Table 23: ACL TOP 300 CTS System - HIT Assay - Product Description
- Table 24: ACL TOP 300 CTS System - Rivaroxaban Test - Product Status
- Table 25: ACL TOP 300 CTS System - Rivaroxaban Test - Product Description
- Table 26: ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay - Product Status
- Table 27: ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay - Product Description
- Table 28: ACL TOP 350 CTS System - Apixaban Test - Product Status
- Table 29: ACL TOP 350 CTS System - Apixaban Test - Product Description
- Table 30: ACL TOP 350 CTS System - Dabigatran Test - Product Status
- Table 31: ACL TOP 350 CTS System - Dabigatran Test - Product Description
- Table 32: ACL TOP 350 CTS System - Rivaroxaban Test - Product Status
- Table 33: ACL TOP 350 CTS System - Rivaroxaban Test - Product Description
- Table 34: ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status
- Table 35: ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description
- Table 36: ACL TOP 500 CTS System - Apixaban Test - Product Status
- Table 37: ACL TOP 500 CTS System - Apixaban Test - Product Description
- Table 38: ACL TOP 500 CTS System - Dabigatran Test - Product Status
- Table 39: ACL TOP 500 CTS System - Dabigatran Test - Product Description
- Table 40: ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Status
- Table 41: ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Description
- Table 42: ACL TOP 500 CTS System - HIT Test - Product Status
- Table 43: ACL TOP 500 CTS System - HIT Test - Product Description
- Table 44: ACL TOP 500 CTS System - Rivaroxaban Test - Product Status
- Table 45: ACL TOP 500 CTS System - Rivaroxaban Test - Product Description
- Table 46: ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status
- Table 47: ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description
- Table 48: ACL TOP 550 CTS System - Apixaban Test - Product Status
- Table 49: ACL TOP 550 CTS System - Apixaban Test - Product Description
- Table 50: ACL TOP 550 CTS System - Dabigatran Test - Product Status
- Table 51: ACL TOP 550 CTS System - Dabigatran Test - Product Description
- Table 52: ACL TOP 550 CTS System - Rivaroxaban Test - Product Status
- Table 53: ACL TOP 550 CTS System - Rivaroxaban Test - Product Description
- Table 54: ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status
- Table 55: ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description
- Table 56: ACL TOP 700 - HIT Test - Product Status
- Table 57: ACL TOP 700 - HIT Test - Product Description
- Table 58: ACL TOP 700 System - Apixaban Test - Product Status
- Table 59: ACL TOP 700 System - Apixaban Test - Product Description
- Table 60: ACL TOP 700 System - Dabigatran Test - Product Status
- Table 61: ACL TOP 700 System - Dabigatran Test - Product Description
- Table 62: ACL TOP 700 System - Global Protein C Pathway Test - Product Status
- Table 63: ACL TOP 700 System - Global Protein C Pathway Test - Product Description
- Table 64: ACL TOP 700 System - Rivaroxaban Test - Product Status
- Table 65: ACL TOP 700 System - Rivaroxaban Test - Product Description
- Table 66: ACL TOP 700 System - VWF Ristocetin Cofactor Activity Assay - Product Status
- Table 67: ACL TOP 700 System - VWF Ristocetin Cofactor Activity Assay - Product Description
- Table 68: ACL TOP 750 CTS System - Apixaban Test - Product Status
- Table 69: ACL TOP 750 CTS System - Apixaban Test - Product Description
- Table 70: ACL TOP 750 CTS System - Dabigatran Test - Product Status
- Table 71: ACL TOP 750 CTS System - Dabigatran Test - Product Description
- Table 72: ACL TOP 750 CTS System - Rivaroxaban Test - Product Status
- Table 73: ACL TOP 750 CTS System - Rivaroxaban Test - Product Description
- Table 74: ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status
- Table 75: ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description
- Table 76: GEM Premier 4000 Analyzer - BUN - Product Status
- Table 77: GEM Premier 4000 Analyzer - BUN - Product Description
- Table 78: GEM Premier 4000 Analyzer - tCO2 Test - Product Status
- Table 79: GEM Premier 4000 Analyzer - tCO2 Test - Product Description
- Table 80: HemosIL AcuStar Multi-Ab Controls - Product Status
- Table 81: HemosIL AcuStar Multi-Ab Controls - Product Description
- Table 82: HemosIL Apixaban Testing Assay - Product Status
- Table 83: HemosIL Apixaban Testing Assay - Product Description
- Table 84: HemosIL Dabigatran Calibrators - Product Status
- Table 85: HemosIL Dabigatran Calibrators - Product Description
- Table 86: HemosIL Dabigatran Controls - Product Status
- Table 87: HemosIL Dabigatran Controls - Product Description
- Table 88: HemosIL Direct Thrombin Inhibitor Assay - Product Status
- Table 89: HemosIL Direct Thrombin Inhibitor Assay - Product Description
- Table 90: HemosIL Rivaroxaban Calibrators - Product Status
- Table 91: HemosIL Rivaroxaban Calibrators - Product Description
- Table 92: HemosIL Rivaroxaban Controls - Product Status
- Table 93: HemosIL Rivaroxaban Controls - Product Description
- Table 94: POC Enzymatic Creatinine Assay - Product Status
- Table 95: POC Enzymatic Creatinine Assay - Product Description
- Table 96: ROTEM sigma Thromboelastometry System - Product Status
- Table 97: ROTEM sigma Thromboelastometry System - Product Description
- Table 98: Instrumentation Laboratory Co, Key Employees
- Table 99: Instrumentation Laboratory Co, Other Locations
- Table 100: Instrumentation Laboratory Co, Subsidiaries
- Table 101: Glossary
- List of Figures
- Figure 1: Instrumentation Laboratory Co Pipeline Products by Equipment Type
- Figure 2: Instrumentation Laboratory Co Pipeline Products by Development Stage